Sign inJoin waitlistJoin the waitlist

Lara Davis

Program Head, Sarcoma Oncology Program, Fred Hutch · University of Washington School of Medicine

Credentials: · · · · ·

History

Sarcoma Oncology Program Division · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Pediatric Hematology Oncology
Oregon Health & Science University
2008–2011
Internal Medicine
2005–2008
Oregon Health & Science University School of Medicine
2001–2005
Neuroscience, Wellesley College
1997–2001

Research

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
The Lancet Oncology · 2017 · 1,203 citations
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Nature Medicine · 2015 · 458 citations
Osteosarcoma, Chondrosarcoma, and Chordoma
Review · Journal of Clinical Oncology · 2018 · 372 citations

CR
Christopher Ryan
12 papers
Richard Riedel
10 papers
CK
Charles Keller
9 papers
Steven Attia
9 papers
BT
Brian Van Tine
6 papers
DR
Damon Reed
6 papers
Elizabeth Loggers
6 papers
Jessica Davis
6 papers
RM
Robert Maki
5 papers
Scott Okuno
5 papers
AM
Atiya Mansoor
4 papers
Katherine Janeway
4 papers

Clinical trials

SMMART Adaptive Clinical Treatment (ACT) Trial
Principal investigator · Withdrawn · Early phase 1
OHSU Knight Cancer Institute
2023–2026
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Principal investigator · Terminated · Phase 1
OHSU Knight Cancer Institute
2020
Progressive Resistance Training for the Improvement of Physical Function
Principal investigator · Completed
OHSU Knight Cancer Institute
2019–2021
Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery
Principal investigator · Active not recruiting · Phase 1
OHSU Knight Cancer Institute
2018–2033